IP Library › Granted Patent US 10,952,985
Granted Patent B2
US 10,952,985 · App. 16/158,002 · Granted Mar 23, 2021

Chlorogenic acid composition for the treatment of metabolic disorders

Inventor: Kodimule Shyam Prasad (Bangalore, IN)
Assignee: Vidya Herbs, Inc.
A61K31/216A61K9/0053A61K36/28A61P3/04A61P3/06A61P3/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,952,985
App. No.
16/158,002
Granted
Mar 23, 2021
Kind
B2
Abstract

A composition of chlorogenic acids and method of its use and manufacture in the treatment of metabolic disorders. The composition can be obtained from sunflower seed extract, including Helianthus annulus seeds.

Claims (13)

1. A method for treating a metabolic disorder, comprising administering to a patient in need thereof sunflower seed extract comprising a mixture of chlorogenic acids, said mixture comprising 3-CQA; 5-CQA; 4-CQA; 3,4-diCQA; 3,5-diCQA; and 4,5-diCQA.

2. The method of claim 1 , wherein said mixture comprises 4.1±1.42 w/w % 3-CQA, 28±4.65 w/w % 5-CQA, 6.5±2.25 w/w % 4-CQA, 0.84±0.26 w/w % 3,4-diCQA, 1.23±0.34 w/w % 3,5-diCQA, and 1.85±0.42 w/w % 4,5-diCQA.

3. The method of claim 1 , wherein said extract has a total chlorogenic acid content of about 42 w/w %.

4. The method of claim 1 , wherein said extract has a total chlorogenic acid content of 42.50±2.5 w/w %.

5. The method of claim 1 , wherein said extract is Helianthus annuus seed extract.

6. The method of claim 1 , wherein administering said extract reduces at least one of glucose, total lipid content, HDL cholesterol, LDL cholesterol, VLDL cholesterol, triglyceride, Lp(a), apoA-I, apoE, and non-esterified fatty acids in the blood of said patient.

7. The method of claim 1 , wherein said metabolic disorder is selected from the group consisting of prediabetes, diabetes, obesity, dyslipidemia, hyperglycemia, and combinations thereof.

8. The method of claim 1 , wherein said metabolic disorder is type 1 diabetes or type 2 diabetes.

9. The method of claim 1 , wherein said extract is administered systemically.

10. The method of claim 1 , wherein said extract is administered by a route selected from the group consisting of orally, buccally, sub-lingually, parenterally, intravenously, intravaginally, rectally, inhalation, and combinations thereof.

11. The method of claim 1 , wherein said extract is administered orally.

12. The method of claim 1 , wherein said extract is in a form selected from the group consisting of powder, liquid, pill, tablet, pellet, capsule, thin film, solution, spray, syrup, linctus, lozenge, pastille, chewing gum, paste, vapor, suspension, emulsion, ointment, cream, lotion, liniment, gel, drop, topical patch, buccal patch, bead, gummy, gel, sol, and injection.

13. The method of claim 1 , wherein said extract further comprises a vitamin, mineral, extract, amino acid, carbohydrate, lipid, excipient, caffeine, flavoring, sweetener, preservative, or combinations thereof.

Continuity (2)
Provisional Application 62571781 · Oct 12, 2017
Related Publication 20190111015A1 · Apr 18, 2019
Cited By (2)
US 12,280,030 US 12,370,164